Cargando…
Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells.
We have produced adriamycin (ADM)-resistant variants of the human lung cancer cell lines NCI-H69 (small cell), MOR (adenocarcinoma) and COR-L23 (large cell) but have failed to produce resistant variants of two other small cell lines. In each case, the derivation protocol took 7-9 months and included...
Autores principales: | Twentyman, P. R., Fox, N. E., Wright, K. A., Bleehen, N. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1986
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001423/ https://www.ncbi.nlm.nih.gov/pubmed/3011054 |
Ejemplares similares
-
Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line.
por: Twentyman, P. R., et al.
Publicado: (1987) -
Characterisation of a mouse tumour cell line with in vitro derived resistance to verapamil.
por: Twentyman, P. R., et al.
Publicado: (1990) -
Characterisation of adriamycin- and amsacrine-resistant human leukaemic T cell lines.
por: Snow, K., et al.
Publicado: (1991) -
Establishment and characterisation of cell lines from patients with lung cancer (predominantly small cell carcinoma).
por: Baillie-Johnson, H., et al.
Publicado: (1985) -
The effects of alpha and gamma interferons on human lung cancer cells grown in vitro or as xenografts in nude mice.
por: Twentyman, P. R., et al.
Publicado: (1985)